M.A. Moral
Impact in
-
- Antibiotics Pharmacokinetics and Efficacy
-
- Antibiotic Resistance in Bacteria
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
-
- Cholinesterase and Neurodegenerative Diseases 2
- Co-authors
- Jesús M. Paramio (2 shared papers)Peter Revill (1 shared paper)M. A. Mangues (1 shared paper)Carmen M. Arroyo (1 shared paper)J. Prous (1 shared paper)Claudio Ballestı́n (1 shared paper)Marcelo dos Santos (1 shared paper)M. Fernanda Lara (1 shared paper)
- Journals
- Drugs of today (2 papers)Drugs of the Future (10 papers)Drug News & Perspectives (1 paper)Oncogene (1 paper)Methods and Findings in Experimental and Clinical Pharmacology (2 papers)
- Partner nations
- Spain
In The Last Decade
M.A. Moral
19 papers receiving 298 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 60
- Molecular Medicine 16
- Molecular Biology 151
- Biological Psychiatry 5
- Oncology 54
Countries citing papers authored by M.A. Moral
This map shows the geographic impact of M.A. Moral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Moral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Moral more than expected).
Fields of papers citing papers by M.A. Moral
This network shows the impact of papers produced by M.A. Moral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Moral. The network helps show where M.A. Moral may publish in the future.
Co-authors
The 17 scholars most cited alongside M.A. Moral, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 78 | |
| 2 | 1997 | 50 | |
| 3 | 2008 | 49 | |
| 4 | 2010 | 39 | |
| 5 | 2006 | 24 | |
| 6 | 2005 | 20 | |
| 7 | 2007 | 9 | |
| 8 | 2010 | 8 | |
| 9 | 2006 | 7 | |
| 10 | 2007 | 6 | |
| 11 | Spotlight on rituximab as a new therapeutic option for dermatomyositis and thrombotic thrombocytopenic purpura. | 2006 | 4 |
| 12 | Spotlight on autoimmune lymphoproliferative syndrome. | 2007 | 3 |
| 13 | 2007 | 3 | |
| 14 | 2007 | 2 | |
| 15 | 2006 | 2 | |
| 16 | 2007 | 2 | |
| 17 | Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis. | 2006 | 2 |
| 18 | Gateways to clinical trials. July-August 2008. | 2008 | 2 |
| 19 | 2007 | 1 | |
| 20 | 2007 | 1 |
About M.A. Moral
M.A. Moral is a scholar working on Molecular Biology, Pharmacology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 22 papers that have together received 312 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Natural Antidiabetic Agents Studies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Alzheimer's disease research and treatments (1 paper), Diabetes and associated disorders (1 paper) and Hormonal and reproductive studies (1 paper). The work is most often cited by research in Pharmacology (60 citations), Molecular Medicine (16 citations), Molecular Biology (151 citations), Biological Psychiatry (5 citations) and Oncology (54 citations). M.A. Moral has collaborated with scholars based in Spain. Frequent co-authors include Jesús M. Paramio, Peter Revill, M. A. Mangues, Carmen M. Arroyo, J. Prous, Claudio Ballestı́n, Marcelo dos Santos, M. Fernanda Lara, Jesús Martínez‐Palacio and Ramón García‐Escudero. Their work appears in journals such as Drugs of today, Drugs of the Future, Drug News & Perspectives, Oncogene and Methods and Findings in Experimental and Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.